Brane Grambozov

5PUBLICATIONS
10CO-AUTHORS
Radiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 17, 2026
Computed tomography monitoring of small lung nodules: finding the right balance.

|Dec 30, 2025
MLR and dMLR Predict Locoregional Control and Progression-Free Survival in Unresectable NSCLC Stage III Patients: Results from the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR).

Alexandra Hochreiter, Markus Stana, Marisa Klebermass

|Dec 24, 2025
Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in Elderly Patients with Unresectable NSCLC Stage III: Subanalysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR).

Franz Zehentmayr, Josef Karner, Markus Stana

|Aug 28, 2025
Delta Changes in [18F]FDG PET/CT Parameters Can Prognosticate Clinical Outcomes in Recurrent NSCLC Patients Who Have Undergone Reirradiation-Chemoimmunotherapy.

Brane Grambozov, Nazanin Zamani-Siahkali, Markus Stana

|Feb 15, 2021
Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysis.

Brane Grambozov, Romana Wass, Markus Stana

Pageof 1

Frequent Collaborators

5 joint publications

Franz Zehentmayr

4 joint publications

Elvis Ruznic

3 joint publications

Markus Stana

2 joint publications

Ayurzana Purevdorj